Trifluridine/Tipiracil Plus Bevacizumab for Vulnerable Patients With Pretreated Metastatic Colorectal Cancer: A Retrospective Study (WJOG14520G).

Yosuke Kito Hiasto KawakamiSeiichiro MitaniShinichi NishinaToshihiko MatsumotoTakao TsuzukiYudai ShinoharaHozumi ShimokawaRyosuke KumanishiTakashi OhtaHiroo KatsuyaTakeshi KawakamiTomohiro NishinaHiroko HasegawaKohei AkiyoshiYasutaka ChibaKentaro YamazakiShuichi HironakaKei Muro

Published in: The oncologist (2023)

Our data show the potential efficacy and acceptable safety profile of FTD/TPI plus bevacizumab for vulnerable patients with pretreated mCRC.

Keyphrases

metastatic colorectal cancer
electronic health record
big data
machine learning
deep learning